Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection
- Resource Type
- Article
- Source
- In
Journal of Microbiology, Immunology and Infection June 2023 56(3):516-525 - Subject
- Language
- ISSN
- 1684-1182